UBS Group AG-Investment Bank & Global Wealth Management's stake in Applied Nutrition Plc fell below 3% (TR-1 holding notification)

RNS Number : 2380Y

Applied Nutrition PLC

08 October 2026

TR-1: Standard form for notification of major holdings

1\. Issuer Details

ISIN

GB00BPVDXX64

Issuer Name

APPLIED NUTRITION PLC

UK or Non-UK Issuer

UK

2\. Reason for Notification

An acquisition or disposal of voting rights; Other

Comments

UBS trading book holdings in Applied Nutrition PLC fell below 5% and are therefore exempt from reporting.

3\. Details of person subject to the notification obligation

Name

UBS Group AG-Investment Bank & Global Wealth Management

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4\. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5\. Date on which the threshold was crossed or reached

07-Oct-2026

6\. Date on which Issuer notified

08-Oct-2026

7\. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	0.000000	0.000000	0.000000	0
Position of previous notification (if applicable)	5.219665	0.016424	5.236089

8\. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BPVDXX64		0		0.000000
Sub Total 8.A	0	0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9\. Information in relation to the person subject to the notification obligation

2\. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
UBS Group AG (Chain 1)
UBS Group AG (Chain 1)	UBS AG

10\. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

11\. Additional Information

UBS trading book holdings in Applied Nutrition PLC fell below 5% and are therefore exempt from reporting.

12\. Date of Completion

08-Oct-2026

13\. Place Of Completion

Zurich, Switzerland

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [\[email protected\]](https://6ix-events-pro.s3.us-east-1.amazonaws.com/cdn-cgi/l/email-protection#daa8b4a99ab6a9bfbdf4b9b5b7) or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUPGPPUUPQGCR